These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Different regulation of miR-29a-3p in glomeruli and tubules in an experimental model of angiotensin II-dependent hypertension: potential role in renal fibrosis. Castoldi G; di Gioia C; Giollo F; Carletti R; Bombardi C; Antoniotti M; Roma F; Zerbini G; Stella A Clin Exp Pharmacol Physiol; 2016 Mar; 43(3):335-42. PubMed ID: 26700017 [TBL] [Abstract][Full Text] [Related]
3. Renal and vascular injury induced by exogenous angiotensin II is AT1 receptor-dependent. Lombardi DM; Viswanathan M; Vio CP; Saavedra JM; Schwartz SM; Johnson RJ Nephron; 2001 Jan; 87(1):66-74. PubMed ID: 11174028 [TBL] [Abstract][Full Text] [Related]
4. SPARC is expressed in renal interstitial fibrosis and in renal vascular injury. Pichler RH; Hugo C; Shankland SJ; Reed MJ; Bassuk JA; Andoh TF; Lombardi DM; Schwartz SM; Bennett WM; Alpers CE; Sage EH; Johnson RJ; Couser WG Kidney Int; 1996 Dec; 50(6):1978-89. PubMed ID: 8943481 [TBL] [Abstract][Full Text] [Related]
5. Role of pressure in angiotensin II-induced renal injury: chronic servo-control of renal perfusion pressure in rats. Mori T; Cowley AW Hypertension; 2004 Apr; 43(4):752-9. PubMed ID: 14981064 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis. Wenzel UO; Thaiss F; Helmchen U; Stahl RA; Wolf G Kidney Int; 2002 Mar; 61(3):1020-9. PubMed ID: 11849457 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kliem V; Johnson RJ; Alpers CE; Yoshimura A; Couser WG; Koch KM; Floege J Kidney Int; 1996 Mar; 49(3):666-78. PubMed ID: 8648907 [TBL] [Abstract][Full Text] [Related]
8. Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II-infused rats. Zou LX; Imig JD; von Thun AM; Hymel A; Ono H; Navar LG Hypertension; 1996 Oct; 28(4):669-77. PubMed ID: 8843896 [TBL] [Abstract][Full Text] [Related]
9. Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension. Graciano ML; Nishiyama A; Jackson K; Seth DM; Ortiz RM; Prieto-Carrasquero MC; Kobori H; Navar LG Am J Physiol Renal Physiol; 2008 Jan; 294(1):F161-9. PubMed ID: 17989111 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Ruiz-Ortega M; Ruperez M; Lorenzo O; Esteban V; Blanco J; Mezzano S; Egido J Kidney Int Suppl; 2002 Dec; (82):S12-22. PubMed ID: 12410849 [TBL] [Abstract][Full Text] [Related]
11. Early interstitial changes in hypertension-induced renal injury. Mai M; Geiger H; Hilgers KF; Veelken R; Mann JF; Dämmrich J; Luft FC Hypertension; 1993 Nov; 22(5):754-65. PubMed ID: 8225535 [TBL] [Abstract][Full Text] [Related]
12. Aggravated renal tubular damage and interstitial fibrosis in mice lacking guanylyl cyclase-A (GC-A), a receptor for atrial and B-type natriuretic peptides. Yoshihara F; Tokudome T; Kishimoto I; Otani K; Kuwabara A; Horio T; Kawano Y; Kangawa K Clin Exp Nephrol; 2015 Apr; 19(2):197-207. PubMed ID: 24845230 [TBL] [Abstract][Full Text] [Related]
13. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape. Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II and IGF-I may interact to regulate tubulointerstitial cell kinetics and phenotypic changes in hypertensive rats. Kobayashi S; Moriya H; Nakabayashi I; Nishiyama J; Fukuda T Hypertens Res; 2002 Mar; 25(2):257-69. PubMed ID: 12047042 [TBL] [Abstract][Full Text] [Related]
15. Renal tubular hypertrophy induced by angiotensin II. Wolf G; Ziyadeh FN Semin Nephrol; 1997 Sep; 17(5):448-54. PubMed ID: 9316213 [TBL] [Abstract][Full Text] [Related]
17. Regulation of angiotensin II type 1 receptor mRNA and protein in angiotensin II-induced hypertension. Harrison-Bernard LM; El-Dahr SS; O'Leary DF; Navar LG Hypertension; 1999 Jan; 33(1 Pt 2):340-6. PubMed ID: 9931127 [TBL] [Abstract][Full Text] [Related]
18. Age-related glomerulosclerosis and interstitial fibrosis in Milan normotensive rats: a podocyte disease. Floege J; Hackmann B; Kliem V; Kriz W; Alpers CE; Johnson RJ; Kühn KW; Koch KM; Brunkhorst R Kidney Int; 1997 Jan; 51(1):230-43. PubMed ID: 8995738 [TBL] [Abstract][Full Text] [Related]
19. Infusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors. Takazawa Y; Maeshima Y; Kitayama H; Yamamoto Y; Kawachi H; Shimizu F; Matsui H; Sugiyama H; Yamasaki Y; Makino H Kidney Int; 2005 Aug; 68(2):704-22. PubMed ID: 16014048 [TBL] [Abstract][Full Text] [Related]
20. Roles of AT1 and AT2 receptors in the hypertensive Ren-2 gene transgenic rat kidney. Zhuo J; Ohishi M; Mendelsohn FA Hypertension; 1999 Jan; 33(1 Pt 2):347-53. PubMed ID: 9931128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]